Clinical Resources

October 1, 2008—The statement focuses on noninvasive risk stratification for primary prevention of sudden cardiac death and is limited to techniques for ischemic, dilated, and hypertrophic cardiomyopathies.

September 26, 2008—This policy update revises the recommendations from the original statement published under the North American Society of Pacing and Electrophysiology (NASPE) in 2001. The current recommendations include revisions to criteria on billing and collection, assistance that should or should not be performed, and the proper supervision necessary.

May 23, 2008—The American College of Cardiology, the American Heart Association, and the Heart Rhythm Society jointly released an update to the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices.

 See 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. See also 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients with Bradycardia and Cardiac Conduction Delay. 

May 14, 2008—This clinical document details the training for ICD/CRT implants in patients who are either in the pediatric age range (birth–18 years of age) with or without congenital heart disease or adults with congenital heart disease. The health care team involved in the care of these patients should have knowledge and expertise about the implantation indications, implantation techniques, complications, programming, and follow-up for these devices, as well as the nontechnical treatment issues relevant to children.

 This document has been retired and replaced by 2013 Recommendations for Advanced Fellowship Training in Clinical Pediatric and Congenital Electrophysiology.

April 24, 2008—This document represents expert consensus concerning the monitoring of cardiovascular implantable electronic devices (CIEDs). The topics covered by this document include the monitoring of CIEDs with a description of the technology, indications for use, personnel involved in monitoring, and the frequency and types of monitoring events. Also covered are issues in regard to data management, regulatory environments, reimbursement and ethical considerations in respect to device inactivation.

 This document has been retired and replaced by 2015 HRS Expert Consensus Statement on Remote Interrogation and Monitoring for Cardiovascular Electronic Implantable Devices. 

February 1, 2008—This document is the result of a close collaboration between the American College of Cardiology's Adult Cardiovascular Medicine Core Cardiology Training (COCATS) Task Force 6 and the Heart Rhythm Society. This Task Force 6 Report is 1 of 13 COCATS 3 Task Force Reports, which encompass training recommendations for the fellowship programs in adult cardiovascular medicine.

December 19, 2007—These guidelines are intended for physicians and nonphysician caregivers who are involved in the preoperative, operative, and postoperative care of patients undergoing noncardiac surgery. They provide a framework for considering cardiac risk of noncardiac surgery in a variety of patient and surgical situations.

 See 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade.

July 28, 2007—Amiodarone is commonly used to treat supraventricular and ventricular arrhythmias in various inpatient and outpatient settings. Because of adverse drug reactions, proper use is essential to deriving optimal benefits from the drug with the least risk.

 This document has been retired because it is no longer current.

May 9, 2007—Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS), this consensus statement provides a state-of-the-art review of the field of catheter and surgical ablation of atrial fibrillation and defines the indications, techniques, and outcomes of this procedure.

 This document has been retired and replaced by 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation.

February 1, 2007—This statement examines the relation of the resting ECG to its technology. Its purpose is to foster understanding of how the modern ECG is derived and displayed and to establish standards that will improve the accuracy and usefulness of the ECG in practice. Derivation of representative waveforms and measurements based on global intervals are described. Special emphasis is placed on digital signal acquisition and computer-based signal processing, which provide automated measurements that lead to computer-generated diagnostic statements. Lead placement, recording methods, and waveform presentation are reviewed. Throughout the statement, recommendations for ECG standards are placed in context of the clinical implications of evolving ECG technology.